Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs TRYM Health

CoraDoc
Site position #50

Higher grade

vs+6.2
TRYM Health
Site position #115

Lower grade

The verdict

CoraDoc takes it — 76.8/100 to 70.6/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
96
96
Dose & formulationEven
72
72
Clinical oversightCoraDoc +24
79
55
Labs & monitoringEven
53
53
FulfillmentCoraDoc +2
76
74
Contract termsCoraDoc +14
69
55
CoraDoc · left barTRYM Health · right bar

The numbers

MetricCoraDocTRYM Health
WeighScore76.8/10070.6/100
GradeCC
Site position#50#115
Semaglutide$99/mo (all doses, compounded)$96/mo (all doses, compounded)
Tirzepatide$165/mo (all doses, compounded)$126/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoraDoc

Site position #50 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

Where it loses points

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site
TRYM Health

Site position #115 · C

FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

Where it loses points

  • Compounding pharmacy partner not named
  • LegitScript certification was not documented on the public pages reviewed
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
  • FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard